Press "Enter" to skip to content

Exclusive Report on Viral Vector Manufacturing Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Viral

The “Viral Vector Manufacturing Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Viral Vector Manufacturing Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Viral Vector Manufacturing market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Viral Vector Manufacturing Market Are:

  • Cobra Biologics
  • Finvector Oy
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Kaneka Corporation (Eurogentec)
  • Merck KGaA
  • Novasep Inc.
  • Oxford BioMedica Plc.
  • Sanofi SA
  • Spark Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099017

    Market Overview:

  • The viral vector manufacturing market is expected to register a CAGR of 19% over the forecast period. Certain factors that are driving the market include the rising prevalence of genetic disorders, cancer, and infectious diseases, the increasing number of clinical studies, and availability of funding for gene therapy development, and potential applications in novel drug delivery approaches.
  • Currently, several viral vector-based drugs have been approved. For instance, Gendicine™, the first gene therapy drug uses an oncolytic adenovirus vector, GlyberaRR (Alipogene tiparvovec) is a recombinant AAV product for lipoprotein lipase deficiency, and StrimvelisR which is a lentivirus vector for severe combined immunodeficiency (SCID) was approved in Europe. Furthermore, the second-generation oncolytic herpes simplex virus-1 expressing GM-CSF (Granulocyte-macrophage colony-stimulating factor) was recently approved for melanoma treatment in Europe and the United States, under the name T-vec (talimogene laherparepvec). Furthermore, there are significant government initiatives for the development of precision and personalized medicine in place, which are supplementing the R&D activities of academia and the industry. The government initiatives are driving the market’s growth through direct funding, increasing awareness, and streamlining the regulatory environment via changes, such as fast track approval processes.
  • Hence, owing to the availability of funding, the market for viral vector manufacturing is expected to grow in the future.

    Scope of the Report:

  • As per the scope of this report, viral vectors represent one of the primary tools that can be used to deliver genetic material into cells. Viral vectors can be utilized in gene therapy, for the treatment of different diseases, such as heart defects, metabolic diseases, cancers, and neurodegenerative disorders. Viral vectors that are based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, and baculovirus, among others, are being routinely used in life science research, and are finding their applications in vaccinology and novel drug delivery approaches.
  • The report gives a detailed analysis of the types of viral vectors, the diseases it deals with, and its applications along with the geographical considerations.

    Viral Vector Manufacturing Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Viral Vector Manufacturing market?
    • What are the key market trends impacting the growth of the global Viral Vector Manufacturing market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Viral Vector Manufacturing market?
    • What are the market opportunities and threats faced by the vendors in the global Viral Vector Manufacturing market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Viral Vector Manufacturing market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099017

    Key Market Trends:

    The Cancer Sub-segment is Expected to Grow Faster in the Disease Segment

    In the field of oncology, viral vector-based gene therapy has demonstrated steady progress. A multitude of viral vectors has been engineered for both therapeutic and preventive applications, in cancers. A critical development in viral vector-based cancer therapy has been the application of engineered and naturally occurring oncolytic viral vectors. These vectors are programmed to specifically replicate inside the cancer cells and induce toxic effects, which ultimately results in apoptosis. The attractive features of viral vectors relate to their capability to provide high levels of transgene expression, in a broad range of host cells.

    The high demand for effective therapeutics for the management of cancers, the presence of fast track approval process, and the prospects of novel drugs to turn into blockbuster products are primary reasons responsible for the significant R&D investments in the field of viral vector-based cancer therapeutics, which, in turn, is driving the market’s growth.

    North America Dominates the Market and is Expected to Follow the Same Trend in the Future As Well

    North America currently dominates the market for viral vector manufacturing and is expected to continue its stronghold for a few more years. The United States holds the largest market share in the North American region owing to factors, such as the high adoption rate of new therapies and high awareness of the general population. The increasing prevalence of genetic and chronic disorders, such as cancer, an aging population, growing demand for targeted and personalized medicine, and favorable government initiatives are the factors responsible for the significant market size in the United States.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Viral Vector Manufacturing Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Viral Vector Manufacturing .

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099017

    Report Objectives:

    • Analyzing the size of the Viral Vector Manufacturing market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Viral Vector Manufacturing market.
    • Determining the key dynamics of the Viral Vector Manufacturing market.
    • Highlighting significant trends of the Viral Vector Manufacturing market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Viral Vector Manufacturing market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Viral Vector Manufacturing market.

    Detailed TOC of Viral Vector Manufacturing Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Prevalence of Genetic Disorders, Cancer, and Infectious Diseases
    4.2.2 Increasing Number of Clinical Studies And Availability of Funding For Gene Therapy Development
    4.2.3 Potential Applications in Novel Drug Delivery Approaches
    4.3 Market Restraints
    4.3.1 High Cost of Gene Therapies
    4.3.2 Challenges in Viral Vector-manufacturing Capacity
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Type
    5.1.1 Adenoviral Vectors
    5.1.2 Adeno-associated Viral Vectors
    5.1.3 Lentiviral Vectors
    5.1.4 Retroviral Vectors
    5.1.5 Other Types
    5.2 By Disease
    5.2.1 Cancer
    5.2.2 Genetic Disorders
    5.2.3 Infectious Diseases
    5.2.4 Other Diseases
    5.3 By Application
    5.3.1 Gene therapy
    5.3.2 Vaccinology
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Cobra Biologics
    6.1.2 Finvector Oy
    6.1.3 Fujifilm Diosynth Biotechnologies U.S.A., Inc.
    6.1.4 Kaneka Corporation (Eurogentec)
    6.1.5 Merck KGaA
    6.1.6 Novasep Inc.
    6.1.7 Oxford BioMedica Plc.
    6.1.8 Sanofi SA
    6.1.9 Spark Therapeutics Inc.
    6.1.10 Thermo Fisher Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Building Thermal Insulation Material Market 2019 Industry Recent Developments, Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2024

    Connected Toys Market 2019 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2024

    Medical Electronics Market 2019 Types and Applications, Market Share, Size, Industry and Development Trend 2024

    Global Full-size Luxury Cars Market 2019: Analysis by Key Development Factors, Latest Trends, Market Size, Share & Outlook and Forecast 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *